The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 31, 2004

Filed:

Nov. 16, 2001
Applicant:
Inventors:

Robert Olmsted, Chapel Hill, NC (US);

Paula Keith, Holly Springs, NC (US);

Sergey Dryga, Chapel Hill, NC (US);

Ian Caley, Durham, NC (US);

Maureen Maughan, Durham, NC (US);

Robert Johnston, Chapel Hill, NC (US);

Nancy Davis, Chapel Hill, NC (US);

Ronald Swanstrom, Chapel HIll, NC (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 ; C12P 2/104 ; C12N 5/16 ; C07H 2/102 ; A61K 3/900 ;
U.S. Cl.
CPC ...
C12Q 1/68 ; C12P 2/104 ; C12N 5/16 ; C07H 2/102 ; A61K 3/900 ;
Abstract

The present invention provides methods and compositions comprising a population of alphavirus replicon particles comprising two or more isolated nucleic acids selected from 1) an isolated nucleic acid encoding an env gene product or an immunogenic fragment thereof of a human immunodeficiency virus, 2) an isolated nucleic acid encoding a g&agr;g gene product or an immunogenic fragment thereof of a human immunodeficiency virus, wherein the g&agr;g gene product or immunogenic fragment thereof is modified to inhibit formation of virus-like particles containing the g&agr;g gene product or the immunogenic fragment thereof and their release from a cell, and 3) an isolated nucleic acid encoding a pol gene product or an immunogenic fragment thereof of a human immunodeficiency virus, wherein the pol gene product or immunogenic fragment thereof is modified to inhibit protease, integrase, RNase H and/or reverse transcriptase activity, and wherein the nucleic acids are each contained within a separate alphavirus replicon particle.


Find Patent Forward Citations

Loading…